Literature DB >> 8995291

Folding and stability of the Z and S(iiyama) genetic variants of human alpha1-antitrypsin.

H A Kang1, K N Lee, M H Yu.   

Abstract

Z (Glu342 --> Lys) and S(iiyama) (Ser53 --> Phe) genetic variations of human alpha1-antitrypsin (alpha1-AT) cause a secretion blockage in the hepatocytes, leading to alpha1-AT deficiency in the plasma. Using in vitro folding analysis, we have shown previously that these mutations interfere with the proper folding of polypeptides. To understand the fundamental cause for the secretion defect of the Z and S(iiyama) variants of alpha1-AT, we investigated in vivo folding and stability of these variant alpha1-AT using the secretion system of yeast Saccharomyces cerevisiae. Various thermostable mutations suppressing the folding block of the Z variant in vitro corrected the secretion defect as well as the intracellular degradation in the yeast secretion system. Significantly, the extent of suppression in the secretion defect of Z protein was proportional to the extent of suppression in the folding defect, assuring that the in vivo defect associated with the Z variant is primarily derived from the folding block. In contrast, the folding and secretion efficiency of S(iiyama) was not much improved by the same mutations. In addition, none of the rarely secreted S(iiyama) alpha1-AT carrying the stabilizing mutations for the wild type and Z variant were active. It appears that the major defect in S(iiyama) variant is the loss of stability in contrast to the kinetic block of folding in the Z variant.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 8995291

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

Review 1.  Liver injury in alpha1-antitrypsin deficiency: an aggregated protein induces mitochondrial injury.

Authors:  David H Perlmutter
Journal:  J Clin Invest       Date:  2002-12       Impact factor: 14.808

Review 2.  Protein misfolding and the serpinopathies.

Authors:  Didier Belorgey; Peter Hägglöf; Susanna Karlsson-Li; David A Lomas
Journal:  Prion       Date:  2007-01-06       Impact factor: 3.931

3.  The requirements of yeast Hsp70 of SSA family for the ubiquitin-dependent degradation of short-lived and abnormal proteins.

Authors:  Do Hee Lee; Michael Y Sherman; Alfred L Goldberg
Journal:  Biochem Biophys Res Commun       Date:  2016-05-10       Impact factor: 3.575

4.  The ubiquitin ligase Hrd1 promotes degradation of the Z variant alpha 1-antitrypsin and increases its solubility.

Authors:  Haiping Wang; Qi Li; Yujun Shen; Aimin Sun; Xiaoguang Zhu; Shengyun Fang; Yuxian Shen
Journal:  Mol Cell Biochem       Date:  2010-10-01       Impact factor: 3.396

Review 5.  Alpha1-antitrypsin deficiency. 4: Molecular pathophysiology.

Authors:  D A Lomas; H Parfrey
Journal:  Thorax       Date:  2004-06       Impact factor: 9.139

6.  The human serpin proteinase inhibitor-9 self-associates at physiological temperatures.

Authors:  Lauren N Benning; James C Whisstock; Jiuru Sun; Phillip I Bird; Stephen P Bottomley
Journal:  Protein Sci       Date:  2004-07       Impact factor: 6.725

Review 7.  Why has it been so difficult to prove the efficacy of alpha-1-antitrypsin replacement therapy? Insights from the study of disease pathogenesis.

Authors:  Jennifer A Dickens; David A Lomas
Journal:  Drug Des Devel Ther       Date:  2011-08-17       Impact factor: 4.162

8.  Aggregation and retention of human urokinase type plasminogen activator in the yeast endoplasmic reticulum.

Authors:  Michael O Agaphonov; Nina V Romanova; Polina M Trushkina; Vladimir N Smirnov; Michael D Ter-Avanesyan
Journal:  BMC Mol Biol       Date:  2002-10-07       Impact factor: 2.946

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.